Integrated proteomics spotlight the proteasome as a therapeutic vulnerability in embryonal tumors with multilayered rosettes
M Dottermusch, A Biabani, T Lempertz… - Neuro …, 2024 - academic.oup.com
Background Embryonal tumors with multilayered rosettes (ETMR) are rare malignant
embryonal brain tumors. The prognosis of ETMR is poor and novel therapeutic approaches …
embryonal brain tumors. The prognosis of ETMR is poor and novel therapeutic approaches …
[HTML][HTML] Integrated proteomics spotlight the proteasome as a therapeutic vulnerability in embryonal tumors with multilayered rosettes
M Dottermusch, A Biabani, T Lempertz… - Neuro …, 2024 - ncbi.nlm.nih.gov
Background Embryonal tumors with multilayered rosettes (ETMR) are rare malignant
embryonal brain tumors. The prognosis of ETMR is poor and novel therapeutic approaches …
embryonal brain tumors. The prognosis of ETMR is poor and novel therapeutic approaches …
Integrated proteomics spotlight the proteasome as a therapeutic vulnerability in embryonal tumors with multilayered rosettes.
M Dottermusch, A Biabani, T Lempertz… - Neuro …, 2024 - europepmc.org
Background Embryonal tumors with multilayered rosettes (ETMR) are rare malignant
embryonal brain tumors. The prognosis of ETMR is poor and novel therapeutic approaches …
embryonal brain tumors. The prognosis of ETMR is poor and novel therapeutic approaches …
Integrated proteomics spotlight the proteasome as a therapeutic vulnerability in embryonal tumors with multilayered rosettes
M Dottermusch, A Biabani, T Lempertz… - Neuro …, 2024 - pubmed.ncbi.nlm.nih.gov
Background Embryonal tumors with multilayered rosettes (ETMR) are rare malignant
embryonal brain tumors. The prognosis of ETMR is poor and novel therapeutic approaches …
embryonal brain tumors. The prognosis of ETMR is poor and novel therapeutic approaches …
Integrated proteomics spotlight the proteasome as a therapeutic vulnerability in embryonal tumors with multilayered rosettes
M Dottermusch, A Biabani, T Lempertz… - Neuro …, 2024 - academic.oup.com
Background Embryonal tumors with multilayered rosettes (ETMR) are rare malignant
embryonal brain tumors. The prognosis of ETMR is poor and novel therapeutic approaches …
embryonal brain tumors. The prognosis of ETMR is poor and novel therapeutic approaches …
Integrated proteomics spotlight the proteasome as a therapeutic vulnerability in Embryonal Tumors with Multilayered Rosettes.
M Dottermusch, A Biabani, T Lempertz… - Neuro …, 2023 - europepmc.org
Background Embryonal tumors with multilayered rosettes (ETMR) are rare malignant
embryonal brain tumors. The prognosis of ETMR is poor and novel therapeutic approaches …
embryonal brain tumors. The prognosis of ETMR is poor and novel therapeutic approaches …